Abstract 1730P
Background
A constellation of a large attack surface of interconnected devices and cyberimmaturity renders healthcare ripe to cybercrime. These vulnerabilities and their consequences will be magnified by the exponential growth in artificial intelligence. We assess the impact and implications of a cyberattack on a national cancer centre.
Methods
On 14 May 2021 (day 0), the first national healthcare ransomware attack occurred within which all hospitals including Cork University Hospital (CUH) Cancer Centre was implicated. Contingency plans were only present in laboratory services who had previously experience information technology (IT) failures. Departmental handwritten logs of activity and responses for 700 days after the attack were reviewed.
Results
Following the attack, all IT systems were shut down. No hospital cyberattack emergency plan was in place. Within CUH, on day 0, all radiotherapy (RT) treatment stopped, outpatient activity fell by 50%, and elective surgery stopped. Haematology, biochemistry and radiology capacity fell by 90% (daily sample deficit (DSD) 2700 samples), 75% (DSD 2,250 samples), and 90% (100% mammography/PETscan) respectively. Histopathology reporting times doubled (7 to 15 days). or paused IT links. Outsourcing of radiology and radiotherapy (RT) commenced, alternative communication networks (e.g., proton mail; Siilo) were utilised and national conference calls for RT and clinical trials were established. 136 patients had interrupted RT: median gap day 6 days category 1, 10 days for remaining patients. By day 28, e-mail communication was restored. By day 210, reporting and data storage backlogs were cleared and over 2000 computers were checked/replaced by the Irish Army. Notification of patients and staff whose data was compromised is ongoing (day 720).
Conclusions
Cyberattacks have rapid, profound and protracted impacts. While laboratory and diagnostic deficits were readily quantified, the impact of disrupted/delayed care on patient outcomes is less readily quantifiable but likely to be much greater. As criminals and nation states weaponize the internet, cyberawareness and cyberattack plans need to be embedded in healthcare.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
R.J. Keogh: Financial Interests, Other, Travel, Accommodations, Expenses: MSD. All other authors have declared no conflicts of interest.
Resources from the same session
1747P - The need for a better discussion between doctors and patients with regards to fertility preservation and vaginal rehab after anti cervical cancer treatments
Presenter: Bar Levy
Session: Poster session 23
1748P - Tackling childhood obesity epidemic on southern Europe through soft drink advertisement policies: Should oncology societies have a say?
Presenter: Konstantinos Kamposioras
Session: Poster session 23
1749P - Prevention of modifiable cancer risks in informal family caregivers of cancer patients: Implementation and evaluation of a personalised primary prevention intervention (PREV-AIDANT)
Presenter: Beatrice Fervers
Session: Poster session 23
1751P - Re-ranking cancer mortality using years of life lost
Presenter: Cecilia Radkiewicz
Session: Poster session 23
1752P - Clinical benefit of immunotherapies in advanced cancer in France: A population-based estimate from 2014 to 2021
Presenter: Isabelle Borget
Session: Poster session 23
1753P - Universal DPYD genotyping in patients with gastrointestinal malignancies: Real-world data from a single institution in Italy
Presenter: Claudia Cardone
Session: Poster session 23
1754P - Towards a next-generation sequencing/comprehensive genomic profiling value framework: Systematic review for identifying new domains and adapting a diagnostic test value framework in Europe
Presenter: Federico Augustovski
Session: Poster session 23
1755P - Carbohydrate quality index and incidence of obesity-related cancers: The Seguimiento Universidad de Navarra (SUN) project
Presenter: Maria Olmedo López-frías
Session: Poster session 23
1756P - Vizcan: A Swedish population-based study to address cancer outcomes using an interactive platform
Presenter: Anders Berglund
Session: Poster session 23